CompuMed Gross Margin 2010-2024 | CMPD
Current and historical gross margin for CompuMed (CMPD) over the last 10 years. The current gross profit margin for CompuMed as of December 31, 2024 is %.
| CompuMed Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $0.00B | $0.00B | 33.33% |
| 2024-09-30 | $0.00B | $0.00B | 50.00% |
| 2024-06-30 | $0.00B | $0.00B | 50.00% |
| 2024-03-31 | $0.00B | $0.00B | 100.00% |
| 2023-12-31 | $0.00B | $0.00B | 0.00% |
| 2023-09-30 | $0.00B | $0.00B | 100.00% |
| 2023-06-30 | $0.01B | $0.00B | 66.67% |
| 2023-03-31 | $0.01B | $0.00B | 57.14% |
| 2022-12-31 | $0.01B | $0.00B | 50.00% |
| 2022-09-30 | $0.01B | $0.00B | 50.00% |
| 2022-06-30 | $0.01B | $0.00B | 57.14% |
| 2022-03-31 | $0.01B | $0.00B | 57.14% |
| 2021-12-31 | $0.01B | $0.00B | 57.14% |
| 2021-09-30 | $0.01B | $0.00B | 66.67% |
| 2021-06-30 | $0.01B | $0.00B | 66.67% |
| 2021-03-31 | $0.01B | $0.00B | 80.00% |
| 2020-12-31 | $0.00B | $0.00B | 100.00% |
| 2020-09-30 | $0.00B | $0.00B | 100.00% |
| 2020-06-30 | $0.00B | $0.00B | 100.00% |
| 2020-03-31 | $0.00B | $0.00B | 100.00% |
| 2019-12-31 | $0.00B | $0.00B | 100.00% |
| 2019-09-30 | $0.00B | $0.00B | 100.00% |
| 2019-06-30 | $0.00B | $0.00B | 100.00% |
| 2019-03-31 | $0.00B | $0.00B | 100.00% |
| 2018-12-31 | $0.00B | $0.00B | 75.00% |
| 2018-09-30 | $0.00B | $0.00B | 50.00% |
| 2018-06-30 | $0.00B | $0.00B | 25.00% |
| 2018-03-31 | $0.00B | 0 | 0.00% |
| 2017-12-31 | $0.00B | 0 | 0.00% |
| 2017-09-30 | $0.00B | 0 | 0.00% |
| 2017-06-30 | $0.00B | 0 | 0.00% |
| 2017-03-31 | $0.00B | 0 | 0.00% |
| 2016-12-31 | $0.00B | 0 | 0.00% |
| 2010-12-31 | $0.00B | 0 | 0.00% |
| 2010-09-30 | $0.00B | 0 | 0.00% |
| 2010-06-30 | $0.00B | 0 | 0.00% |
| 2010-03-31 | $0.00B | 0 | 0.00% |
| 2009-12-31 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.005B | $0.006B |
| COMPUMED, INC. is a medical systems company engaged primarily in the application of computer technology to medicine. The main aspects of Co.'s business are (i) the licensing of its proprietary technology in the OsteoGramR, a bone density test that was developed by the Company as a means of aiding physicians in diagnosing and monitoring osteoporosis, (ii) the computer interpretation of electrocardiograms, (iii) TeleCor Services Division, which is engaged in transtelephonic cardiac event monitoring. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.441B | 27.47 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $143.752B | 30.06 |
| EssilorLuxottica (ESLOY) | France | $130.179B | 0.00 |
| Medtronic (MDT) | Ireland | $103.476B | 14.67 |
| Haleon (HLN) | United Kingdom | $50.182B | 28.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.251B | 0.00 |
| ResMed (RMD) | United States | $35.607B | 26.74 |
| GE HealthCare Technologies (GEHC) | United States | $31.667B | 15.03 |
| Agilent Technologies (A) | United States | $30.942B | 20.44 |
| Terumo (TRUMY) | Japan | $27.686B | 35.96 |
| Insulet (PODD) | United States | $22.616B | 88.77 |
| Koninklijke Philips (PHG) | Netherlands | $21.196B | 15.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.329B | 11.77 |
| Baxter (BAX) | United States | $15.457B | 11.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.090B | 21.19 |
| Lantheus Holdings (LNTH) | United States | $5.110B | 12.89 |
| Prestige Consumer Healthcare (PBH) | United States | $4.237B | 18.93 |
| Perrigo (PRGO) | Ireland | $3.651B | 9.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| Haemonetics (HAE) | United States | $3.173B | 14.45 |
| Envista Holdings (NVST) | United States | $2.834B | 23.55 |
| GN Store Nord (GNNDY) | Denmark | $2.054B | 17.01 |
| QuidelOrtho (QDEL) | United States | $2.011B | 13.83 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.11 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.315B | 16.83 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.185B | 12.03 |
| Green Thumb Industries (GTBIF) | United States | $1.145B | 25.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.035B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.04 |
| InMode (INMD) | Israel | $0.899B | 9.06 |
| Evolus (EOLS) | United States | $0.624B | 0.00 |
| CeriBell (CBLL) | United States | $0.599B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.569B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Owens & Minor (OMI) | United States | $0.498B | 4.13 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Surmodics (SRDX) | United States | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.336B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.325B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 55.00 |
| Sanara MedTech (SMTI) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.231B | 10.48 |
| TriSalus Life Sciences (TLSI) | United States | $0.210B | 0.00 |
| Brainsway (BWAY) | Israel | $0.203B | 53.65 |
| Biote (BTMD) | United States | $0.201B | 5.66 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.22 |
| Exagen (XGN) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 0.00 |
| Jin Medical (ZJYL) | China | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.058B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.71 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |